Current CRISPR guide RNAs are designed based on European reference genomes, leading to false-negative results in cells from ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...

CRISPR Therapeutics is revolutionizing medicine with gene editing. Learn more about CRSP's breakthroughs, stock rally, and ...

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

When it comes to groundbreaking biotech advancements, Eric Faw Intellia is a name you might wanna keep an eye on. This ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Analysts have also weighed in on stock throughout the month. Recent analyst calls on the stock include: Needham analyst Gil ...

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR ...

CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and ...

Advancements in gene editing, strategic partnerships, and supportive regulations fuel global CRISPR adoption across healthcare and agriculture. DELAWARE, DE, UNITED STATES, July 14, 2025 /EINPresswire ...

Scientists have created a near-copy of the long-extinct dire wolf. Using advanced CRISPR gene editing tech, it now looks ...

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.